We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

195 hedge funds and large institutions have $458M invested in SANGAMO THERAPEUTICS INC in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $3.64M | Put options by funds: $1.95M

1.37% more ownership

Funds ownership: 52.79%54.16% (+1.4%)

1% more funds holding

Funds holding: 193195 (+2)

7% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 28

2% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 56

20% less capital invested

Capital invested by funds: $571M → $458M (-$114M)

Holders
195
Holders Change
+2
Holders Change %
+1.04%
% of All Funds
3.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
57
Reduced
56
Closed
28
Calls
$3.64M
Puts
$1.95M
Net Calls
+$1.69M
Net Calls Change
-$783K
Name Holding Trade Value Shares
Change
Change in
Stake
Nordea Investment Management
26
Nordea Investment Management
Sweden
$3.94M +$196K +32,988 +5%
Wells Fargo
27
Wells Fargo
California
$3.39M -$123K -20,622 -3%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$3.29M -$1.24M -208,800 -27%
GLA
29
Great Lakes Advisors
Illinois
$3.04M -$770K -129,493 -20%
Citadel Advisors
30
Citadel Advisors
Florida
$2.98M -$887K -149,208 -23%
Rafferty Asset Management
31
Rafferty Asset Management
New York
$2.86M +$685K +115,124 +31%
UBS Group
32
UBS Group
Switzerland
$2.67M +$309K +51,968 +13%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.58M +$24K +4,035 +0.9%
Mirae Asset Global Investments
34
Mirae Asset Global Investments
South Korea
$2.23M -$421K -70,884 -16%
Two Sigma Investments
35
Two Sigma Investments
New York
$2.09M -$737K -123,948 -26%
William Blair & Company
36
William Blair & Company
Illinois
$2M
LFCM
37
Long Focus Capital Management
Puerto Rico
$1.98M +$565K +95,000 +39%
Voloridge Investment Management
38
Voloridge Investment Management
Florida
$1.94M +$1.98M +333,082 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.7M +$134K +22,600 +8%
PPA
40
Parametric Portfolio Associates
Washington
$1.32M +$497K +83,636 +58%
Group One Trading
41
Group One Trading
Illinois
$1.3M -$93K -15,643 -7%
PIM
42
Platinum Investment Management
Australia
$1.27M
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$1.23M -$309K -52,020 -20%
PAM
44
Panagora Asset Management
Massachusetts
$1.16M -$2.39M -401,576 -67%
BPC
45
Banque Pictet & Cie
Switzerland
$1.05M +$41.6K +6,999 +4%
Ohio Public Employees Retirement System (OPERS)
46
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.03M
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$903K -$77.7K -13,074 -8%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$901K
GSEP
49
Golden State Equity Partners
California
$897K +$63K +10,592 +7%
AllianceBernstein
50
AllianceBernstein
Tennessee
$884K +$1.78K +300 +0.2%

SGMO Hedge Fund Activity: Q1 2022 in Review

195 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2022, worth a combined $458M — down 20% from $571M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SGMO positions and 28 closed out — a net gain of 2 holders — while 57 added to existing stakes and 56 trimmed.

The largest buyer was State Street, adding an estimated $9.34M. The largest seller was Lombard Odier Asset Management (Switzerland), cutting an estimated $4.04M.

  • 195 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2022, up from 193 in Q4 2021.
  • Funds reported $458M of SANGAMO THERAPEUTICS INC stock for Q1 2022, down 20% quarter-over-quarter.
  • 30 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2022 and 28 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2022 was State Street, an estimated $9.34M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2022 was Lombard Odier Asset Management (Switzerland), an estimated $4.04M sold.

Based on aggregated 13F filings for Q1 2022.